[
1. Chakrabarti S., What’s in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatr. 2014; 4(2): 30-3610.5498/wjp.v4.i2.30
]Search in Google Scholar
[
2. Dinwiddie R, Müller WG., Adolescent treatment compliance in asthma. J R Soc Med. 2002, 95(2): 6871.10.1177/014107680209500204
]Search in Google Scholar
[
3. Rafii F, Fatemi NS, Danielson E, Johansson CM, and Modanloo M, Compliance to treatment in patients with chronic illness: A concept exploration, Iran J Nurs Midwifery Res., 2014, 19(2): 159167
]Search in Google Scholar
[
4. Bogart M, Stanford RH, Laliberté F et al Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population. Int J Chron Obstruct Pulmon Dis. 2019; 14: 343352
]Search in Google Scholar
[
5. Global Initiative for Asthma (GINA): Global strategy for asthma management and prevention. Update 2019 and Online Appendix. Available at http://www.ginasthma.org.
]Search in Google Scholar
[
6. Accordini S, Corsico AG, Braggion M, et al, The cost of persistent asthma in Europe: an international population-based study in adults. Int Arch Allergy Immunol. 2013;160:93101.
]Search in Google Scholar
[
7. Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:110.1186/s40733-016-0029-3
]Search in Google Scholar
[
8. Cisternas MG, Blanc PD, Yen IH, et al, A comprehensive study of the direct and indirect costs of adult asthma, J Allergy Clin Immunol. 2003;111:12128.10.1067/mai.2003.1449
]Search in Google Scholar
[
9. National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health, https://www.cdc.gov/copd/infographics/copd-costs.html, reviewed: February 21, 2018
]Search in Google Scholar
[
10. Bender BG., Rand C. Medication non-adherence and asthma treatment cost Curr Opin Allergy Clin Immunol. 2004;4(3):191-5.10.1097/00130832-200406000-00009
]Search in Google Scholar
[
11. Rogliani P, Ora J, Puxeddu E, Matera MG, Cazzola M, Adherence to COPD treatment: Myth and reality, Respiratory Medicine, 2017, 129, 117-12310.1016/j.rmed.2017.06.007
]Search in Google Scholar
[
12. Mãgureanu I.L., Furtunescu F - Importanţa determinãrii prevalenţei BPOC, pneumologia.eu/ download-312.htm
]Search in Google Scholar
[
13. Mihãlţan F, Daramus I, Paunescu B, Nemes R, Farcasanu D. Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Romania, 2012, Chest 142(4_MeetingAbstracts):658A10.1378/chest.1389539
]Search in Google Scholar
[
14. Mihãlţan F, Ulmeanu R, Nemeş R, Nedelcu R, Chronic obstructive pulmonary disease day a traditional strategy of the Romanian Society of Pneumology, Pneumologia 2020, Volume 68: Issue 410.2478/pneum-2019-0034
]Search in Google Scholar
[
15. Nicolaescu O- Astmul bronşic, Pneumologie [1 mai 2013 30 aprilie 2014]
]Search in Google Scholar
[
16. Program iniţiat de Societatea Românã de Pneumologie şi implementat de S.C. Totem Communication SRL https://program-inspiro.ro/
]Search in Google Scholar
[
17. Mihaltan F, Adir Y, Antczak A et al., Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study, Respiratory Research, 2019, 20, 8910.1186/s12931-019-1053-7
]Search in Google Scholar
[
18. National Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report, Clinical Practice Guidelines, 2007, 07-4051
]Search in Google Scholar
[
19. Global Initiative for Chronic Obstructive Lung Disease http://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf
]Search in Google Scholar
[
20. Jones JW, Harding G, Berry P et al, Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):64854.
]Search in Google Scholar
[
21. Cochrane GM, Horne R, Chanez P; Compliance in asthma, Respiratory Medicine, 1999, 93, 763-76910.1016/S0954-6111(99)90260-3
]Search in Google Scholar
[
22. Gold DT, McClung B Approaches to patient education: emphasizing the long-term value of compliance and persistence Am J Med 2006;119(4 Suppl 1):S32-7.10.1016/j.amjmed.2005.12.021
]Search in Google Scholar
[
23. Bourbeau J., Bartlett S.J., Patient adherence in COPD, Thorax, 63 (9) (2008), pp. 831-838
]Search in Google Scholar
[
24. Leventhal H, Diefenbach M, Leventhal EA. Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cognitive Ther Res 1992; 16: 143-163.10.1007/BF01173486
]Search in Google Scholar
[
25. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing cognitive representations of medication. Psycho1 Health 1999; 14: l-24.10.1080/08870449908407311
]Search in Google Scholar
[
26. Petrie KJ, Weinman J, Sharpe N, Buckley J. Predicting return to work and functioning following myocardial infarction: the role of the patient’s view of their illness. B Med J 1996; 312: 1191-1194.10.1136/bmj.312.7040.1191
]Search in Google Scholar
[
27. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to reatment in chronic physical illness. J Psychosom Res, 1999;47(6):555-67.10.1016/S0022-3999(99)00057-4
]Search in Google Scholar
[
28. Nides MA, Tashkin DP, Simmons MS et al. Improving inhaler adherence in a clinical trial through the use of the Nebulizer Chronolog. Chest 1993; 104: 501-50710.1378/chest.104.2.5018339641
]Search in Google Scholar
[
29. Engelkes M., Janssens HM, Johan C. de Jongste et al Medication adherence and the risk of severe asthma exacerbations: a systematic review, European Respiratory Journal 2015 45: 396-40710.1183/09031936.0007561425323234
]Search in Google Scholar
[
30. Watz H, Troosters T, Beeh KM et al., ACTIVATE: the effect of aclidinium/formoterol on hyperinflation, exercise capacity, and physical activity in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:254558.10.2147/COPD.S143488557469928883722
]Search in Google Scholar
[
31. Gaude G, Hattiholi J, Chaudhury A, Poor compliance to inhaler therapy in bronchial asthma patients a prospective study in general population, Science Journal of Clinical Medicine 1.2014; 3(1): 4-910.11648/j.sjcm.20140301.12
]Search in Google Scholar
[
32. Ayele A.A., Tegegn H.G., Non adherence to inhalational medications and associated factors among patients with asthma in a referral hospital in Ethiopia, using validated tool TAI Asthma Research and Practice, 2017 volume 3, Article number: 710.1186/s40733-017-0035-0563959229046815
]Search in Google Scholar
[
33. McDonald V.M., Yorke J., Adherence in severe asthma: time to get it right, European Respiratory Journal 2017 50: 170219110.1183/13993003.02191-2017
]Search in Google Scholar
[
34. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients’ compliance with prescribed oral and inhaled asthma medications. Arch Zntern Med 1994; 154: 1349-1352
]Search in Google Scholar
[
35. Yeung M, O’Connor SA, Parry DT, Cochrane GM. Compliance with prescribed drug therapy in asthma. Respir Med 1994; 88: 31-3510.1016/0954-6111(94)90171-6
]Search in Google Scholar
[
36. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Zntern Med 1990; 150: 1881-1884
]Search in Google Scholar
[
37. Coutts JAP, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67: 332-333.10.1136/adc.67.3.33217936771575560
]Search in Google Scholar
[
38. Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest 1993; 104: 1332-1337.10.1378/chest.104.5.13328222783
]Search in Google Scholar
[
39. Malton A, Sumby BS, Dandiker Y. A comparison of invitro drug delivery from salbutamol Diskus and terbutaline Turbohaler inhalers. J Pharm Med 1996; 6: 3548
]Search in Google Scholar
[
40. López-Campos JL Quintana G E, Carrasco H L, Status of and strategies for improving adherence to COPD treatment, 2019,14,1503151510.2147/COPD.S170848662809731371936
]Search in Google Scholar
[
41. Blackstock FC, ZuWallack R, Nici L, Lareau SC. Why Don’t Our Patients with Chronic Obstructive Pulmonary Disease Listen to Us? The Enigma of Nonadherence, 2015, 13, 310.1513/AnnalsATS.201509-600PS26882499
]Search in Google Scholar
[
42. Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 2006;118:899904.10.1016/j.jaci.2006.07.00217030244
]Search in Google Scholar
[
43. Cecere LM, Slatore CG, Uman JE et al., Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD 2012;9:251258.10.3109/15412555.2011.65024122497533
]Search in Google Scholar
[
44. Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD. 2012;9(3):251258.10.3109/15412555.2011.650241
]Search in Google Scholar
[
45. Lindsay JT, Heaney LG, Nonadherence in difficult asthma facts, myths, and a time to act, Patient Prefer Adherence. 2013; 7: 329336
]Search in Google Scholar
[
46. Rolnick S.J., Pawloski P.A., Hedblom B.D., Asche S.E., Bruzek R.J., Patient characteristics associated with medication adherence, Clin. Med. Res., 2013, 11 (2),54-6510.3121/cmr.2013.1113369238923580788
]Search in Google Scholar
